{"Title": ["NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps", "Bellicum Pharma (BLCM) Up 140% In A Month, To Report BPX-601 Data On Jan.24", "Health Care Sector Update for 12/11/2019: BLCM,SAGE,GENE,RCKT", "Aratana Therapeutics (PETX) in Focus: Stock Moves 6.8% Higher", "Bellicum Pharmaceuticals Enters Oversold Territory", "Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA", "Novan Announces Top-Line Data From Mid-Stage Molluscum Study", "Bellicum Pharmaceuticals (BLCM) Reports Q3 Loss, Tops Revenue Estimates", "NTLA Gains On Amended REGN Deal, GILD Reports SIMPLE Results, MYOV On Watch, NVUS Slumps", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. Alnylam Pharmaceuticals, Inc.", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. bluebird bio", "Here's Why Bellicum Pharmaceuticals Is Jumping Higher Today", "Is Bellicum Pharmaceuticals, Inc. a Buy?", "10 Cheap Stocks to Buy With Only $10", "Biotech Stock Roundup: ALKS Up, CLDX Down, ALXN to Acquire Wilson Therapeutics", "Here's Why Bellicum Pharmaceuticals Dropped as Much as 14.6% Today", "Here's Why Bellicum Pharmaceuticals Lost 13.8% in July", "Company News For Apr 12, 2018", "Is Bellicum Pharmaceuticals Stock Now a Strong Buy?", "Pre-Market Most Active for Apr 12, 2018 : BBBY, TVIX, ABB, FB, QQQ, SBGL, FTI, BLCM, SQQQ, DAL, AZN, BAC", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. Alnylam", "Wall Street Set for Strong Open, US Inflation Rises In-Line with Expectations", "Health Care Sector Update for 03/13/2018: ABBV, BLCM, EPZM, MRK", "US Futures Edge Higher, Inflation Data in Focus", "FDA Lifts Clinical Hold on Bellicum's (BLCM) T Cell Therapy", "Health Care Sector Update for 03/13/2018: EPZM,BLCM,MRK", "Health Care Sector Update for 02/23/2018: BLCM, PFE, PBYI, AMGN, 4507:JP", "Health Care Sector Update for 02/23/2018: AMGN,PBYI,BLCM,PFE", "Health Care Sector Update for 02/23/2018: PBYI, BLCM, PFE", "Is Bellicum Pharmaceuticals, Inc. a Buy Now?", "Why Bellicum Pharmaceuticals Stock Is Crashing Today", "Health Care Sector Update for 03/13/2018: ABBV,NBIX,EPZM,BLCM,MRK", "Health Care Sector Update for 01/31/2018: BLCM,TMO,AMTM,LLY", "Will 2018 Be Bellicum Pharmaceuticals, Inc.'s Best Year Yet?", "Why Juno Therapeutics Stock Is Soaring Today", "Bellicum Pharmaceuticals Is Failing to Capture Investors' Imagination", "Are Viruses a Problem for CAR-T Drugmakers?", "3 Stocks Changing the Future of Healthcare", "3 Stocks You'll Brag About Owning Someday", "Health Care Sector Update for 01/31/2018: JNJ, PFE, ABT, MRK, AMGN, LLY, BLCM, ANTM, PLX, TMO, BGNE", "Health Care Sector Update for 01/31/2018: BLCM,TMO,AMTM,LLY", "Will 2018 Be Bellicum Pharmaceuticals, Inc.'s Best Year Yet?", "Bellicum Pharmaceuticals (BLCM) in Focus: Stock Moves 13.8% Higher", "UQM Technologies, Kite Pharma Jump on Monday", "3 Value Stocks for Sharp Investors", "Can Bellicum Pharmaceuticals Stock Bounce Back?", "Here's Why Bellicum Pharmaceuticals Fell as Much as 13.8% Today", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. bluebird bio", "Health Care Sector Update for 06/29/2017: PTI,OBSV,BLCM", "3 Growth Stocks You Haven't Thought Of", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. Kite Pharma", "Pre-Market Most Active for Mar 24, 2017 : MU, MYL, HTGM, CHMI, BLCM, FINL, BAC, STM, EBIO, TWTR, SNAP, TTM", "After-Hours Earnings Report for March 13, 2017 : CHRS, IPAR, IRET, KMG, BLCM, RYI, ENZ, GDEN, BREW, LMNR, PETX, RSO", "Wednesday Sector Leaders: Drugs, Computer Peripherals", "Here's Why Bellicum Pharmaceuticals Went Up as Much as 22% Today", "Health Care Sector Update for 06/29/2017: SRNE,OBSV,BLCM", "Moving Average Crossover Alert: Bellicum Pharmaceuticals (BLCM)", "Better Buy: Ionis Pharmaceuticals, Inc. vs. Bellicum Pharmaceuticals", "Why Juno Therapeutics Inc Plummeted Today", "Better Buy: Agenus Inc. vs. Bellicum Pharmaceuticals Inc.", "2 Cancer Therapy Stocks That Are Ridiculously Cheap Right Now", "Bellicum Pharmaceuticals (BLCM) is in Overbought Territory: What's Next?", "Better Buy: Bellicum Pharmaceuticals, Inc. vs. Celldex Therapeutics", "Better Buy: Bellicum Pharmaceuticals Inc. vs. bluebird bio Inc.", "Here's Why bluebird bio's Shares Dropped 10% on Monday", "Analysts Predict 34% Gains Ahead For IBB", "Health Care Sector Update for 04/05/2016: BLCM,VRX,AGN,PFE", "Thursday Sector Leaders: Drugs, Biotechnology Stocks", "After-Hours Earnings Report for March 14, 2016 : TTEC, INGN, MNKD, AKBA, BLCM, PFSW, RXDX, JMBA, CUI, TPVG, DCO, RST", "Why bluebird bio Inc.'s Stock Dropped 34% in January", "2 Beaten-Down Biotech Stocks to Buy in February", "Cancer Stocks: 2 to Buy, 1 to Avoid", "Here's Why Bluebird Bio Turned in a Disappointing 2015", "Here's Why Juno Therapeutics' Stock Dropped 20% in December", "My Top Biotech Stock for 2016", "2 Biotech Stocks to Watch in December", "Health Care Sector Update for 11/10/2015: BLCM, SPHS, AEGR", "Why Bellicum Pharmaceuticals Is Soaring Today", "3 Biotech Stocks We're Ready to Sell", "Why Bluebird Bio Inc.'s Stock Bounced Back", "Why Bellicum Pharmaceuticals (BLCM) Could Be Positioned for a Slump", "George Soros' Fund Just Abandoned This Promising Cancer-Fighting Technology: Should You?", "3 Small-Cap Biopharma Stocks I'd Never Short", "What Is Cancer Immunotherapy?", "Bellicum Pharmaceuticals Slumps: BLCM Falls 9.6% in Session - Tale of the Tape", "Billionaire George Soros Just Bought This Highly Speculative Stock -- Should You?", "3 Stocks That Could Double Your Money", "Health Care Sector Update for 09/11/2015: BLCM,ARWR,NWBO", "Could This Tiny Biotech Be on Gilead Sciences\u2019 M&A Radar?", "Bellicum Pharmaceuticals, Inc. (BLCM) in Focus: Stock Jumps 6.1% - Tale of the Tape", "A $10 Billion Hedge Fund Just Bought This Extremely Risky Stock; Should You?", "Top-Rated Stock Picks and Most-Read Stories at Nasdaq.com: Feb. 1-7, 2015", "2 Companies Redefining Cancer Treatment", "US IPO Weekly Recap: Record 2014 IPO market finishes with a $2 billion cancer biotech", "Bellicum Pharmaceuticals prices upsized IPO at $19, above the range", "2 Stocks With Jaw-Dropping Growth Potential", "Week ahead: The 2014 IPO market's final round with 6 IPOs planned for the week of Dec 15", "Double dose of immunotherapy: Bellicum Pharmaceuticals sets terms for $100 million IPO", "Juno Therapeutics significantly boosts IPO price range to $21 to $23"], "Elapsed Time": ["JUN 2, 2020", "JAN 18, 2020", "DEC 11, 2019", "JAN 22, 2019", "DEC 27, 2018", "DEC 24, 2018", "DEC 11, 2018", "NOV 6, 2018", "JUN 2, 2020", "JUN 3, 2018", "MAY 24, 2018", "MAY 9, 2018", "APR 24, 2018", "APR 24, 2018", "APR 18, 2018", "APR 17, 2018", "AUG 4, 2018", "APR 12, 2018", "APR 12, 2018", "APR 12, 2018", "MAR 22, 2018", "MAR 13, 2018", "MAR 13, 2018", "MAR 13, 2018", "APR 12, 2018", "MAR 13, 2018", "FEB 23, 2018", "FEB 23, 2018", "FEB 23, 2018", "FEB 10, 2018", "JAN 31, 2018", "MAR 13, 2018", "JAN 31, 2018", "JAN 25, 2018", "JAN 17, 2018", "JAN 5, 2018", "NOV 30, 2017", "NOV 6, 2017", "OCT 21, 2017", "JAN 31, 2018", "JAN 31, 2018", "SEP 18, 2017", "AUG 29, 2017", "AUG 28, 2017", "JUL 16, 2017", "JUL 14, 2017", "JUN 29, 2017", "SEP 28, 2017", "JUN 29, 2017", "MAY 17, 2017", "MAR 29, 2017", "MAR 24, 2017", "MAR 13, 2017", "MAR 8, 2017", "MAR 8, 2017", "JUN 29, 2017", "FEB 13, 2017", "DEC 12, 2016", "NOV 23, 2016", "OCT 18, 2016", "AUG 18, 2016", "AUG 17, 2016", "AUG 3, 2016", "MAR 6, 2017", "JUN 28, 2016", "MAY 31, 2016", "APR 5, 2016", "MAR 24, 2016", "MAR 14, 2016", "FEB 8, 2016", "FEB 6, 2016", "JUL 23, 2016", "JAN 9, 2016", "JAN 7, 2016", "JAN 5, 2016", "NOV 20, 2015", "NOV 10, 2015", "NOV 10, 2015", "OCT 18, 2015", "JAN 13, 2016", "AUG 26, 2015", "AUG 19, 2015", "AUG 12, 2015", "JUN 21, 2015", "JUN 17, 2015", "MAY 31, 2015", "MAY 30, 2015", "SEP 11, 2015", "MAY 16, 2015", "MAR 20, 2015", "MAR 7, 2015", "FEB 10, 2015", "JAN 23, 2015", "DEC 19, 2014", "DEC 18, 2014", "MAY 17, 2015", "DEC 15, 2014", "DEC 9, 2014", "DEC 16, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/ntla-gains-on-amended-regn-deal-gild-reports-simple-results-myov-on-watch-nvus-slumps-2020", "https://www.nasdaq.com/articles/bellicum-pharma-blcm-up-140-in-a-month-to-report-bpx-601-data-on-jan.24-2020-01-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-11-2019%3A-blcmsagegenerckt-2019-12-11", "https://www.nasdaq.com/articles/aratana-therapeutics-petx-in-focus%3A-stock-moves-6.8-higher-2019-01-22", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-enters-oversold-territory-2018-12-27", "https://www.nasdaq.com/articles/jazz-jazz-falls-as-sleep-drug-gets-extended-review-from-fda-2018-12-24", "https://www.nasdaq.com/articles/novan-announces-top-line-data-from-mid-stage-molluscum-study-2018-12-11", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-blcm-reports-q3-loss-tops-revenue-estimates-2018-11-06", "https://www.nasdaq.com/articles/ntla-gains-on-amended-regn-deal-gild-reports-simple-results-myov-on-watch-nvus-slumps-2020", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-alnylam-pharmaceuticals-inc-2018-06-03", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-bluebird-bio-2018-05-24", "https://www.nasdaq.com/articles/heres-why-bellicum-pharmaceuticals-jumping-higher-today-2018-05-09", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-inc-buy-2018-04-24", "https://www.nasdaq.com/articles/10-cheap-stocks-buy-only-10-2018-04-24", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alks-up-cldx-down-alxn-to-acquire-wilson-therapeutics-2018-04-18", "https://www.nasdaq.com/articles/heres-why-bellicum-pharmaceuticals-dropped-much-146-today-2018-04-17", "https://www.nasdaq.com/articles/heres-why-bellicum-pharmaceuticals-lost-138-july-2018-08-04", "https://www.nasdaq.com/articles/company-news-for-apr-12-2018-2018-04-12", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-stock-now-strong-buy-2018-04-12", "https://www.nasdaq.com/articles/pre-market-most-active-apr-12-2018-bbby-tvix-abb-fb-qqq-sbgl-fti-blcm-sqqq-dal-azn-bac", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-alnylam-2018-03-22", "https://www.nasdaq.com/articles/wall-street-set-strong-open-us-inflation-rises-line-expectations-2018-03-13", "https://www.nasdaq.com/articles/health-care-sector-update-03132018-abbv-blcm-epzm-mrk-2018-03-13", "https://www.nasdaq.com/articles/us-futures-edge-higher-inflation-data-focus-2018-03-13", "https://www.nasdaq.com/articles/fda-lifts-clinical-hold-on-bellicums-blcm-t-cell-therapy-2018-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-03132018-epzmblcmmrk-2018-03-13", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-blcm-pfe-pbyi-amgn-4507jp-2018-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-amgnpbyiblcmpfe-2018-02-23", "https://www.nasdaq.com/articles/health-care-sector-update-02232018-pbyi-blcm-pfe-2018-02-23", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-inc-buy-now-2018-02-10", "https://www.nasdaq.com/articles/why-bellicum-pharmaceuticals-stock-crashing-today-2018-01-31", "https://www.nasdaq.com/articles/health-care-sector-update-03132018-abbvnbixepzmblcmmrk-2018-03-13", "https://www.nasdaq.com/articles/health-care-sector-update-01312018-blcmtmoamtmlly-2018-01-31", "https://www.nasdaq.com/articles/will-2018-be-bellicum-pharmaceuticals-incs-best-year-yet-2018-01-25", "https://www.nasdaq.com/articles/why-juno-therapeutics-stock-soaring-today-2018-01-17", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-failing-capture-investors-imagination-2018-01-05", "https://www.nasdaq.com/articles/are-viruses-problem-car-t-drugmakers-2017-11-30", "https://www.nasdaq.com/articles/3-stocks-changing-future-healthcare-2017-11-06", "https://www.nasdaq.com/articles/3-stocks-youll-brag-about-owning-someday-2017-10-21", "https://www.nasdaq.com/articles/health-care-sector-update-01312018-jnj-pfe-abt-mrk-amgn-lly-blcm-antm-plx-tmo-bgne-2018-01", "https://www.nasdaq.com/articles/health-care-sector-update-01312018-blcmtmoamtmlly-2018-01-31", "https://www.nasdaq.com/articles/why-bellicum-pharmaceuticals-stock-rising-today-2017-09-18", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-blcm-in-focus%3A-stock-moves-13.8-higher-2017-08-29", "https://www.nasdaq.com/articles/uqm-technologies-kite-pharma-jump-monday-2017-08-28", "https://www.nasdaq.com/articles/3-value-stocks-sharp-investors-2017-07-16", "https://www.nasdaq.com/articles/can-bellicum-pharmaceuticals-stock-bounce-back-2017-07-14", "https://www.nasdaq.com/articles/heres-why-bellicum-pharmaceuticals-fell-much-138-today-2017-06-29", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-bluebird-bio-2017-09-28", "https://www.nasdaq.com/articles/health-care-sector-update-06292017-ptiobsvblcm-2017-06-29", "https://www.nasdaq.com/articles/3-growth-stocks-you-havent-thought-2017-05-17", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-kite-pharma-2017-03-29", "https://www.nasdaq.com/articles/pre-market-most-active-mar-24-2017-mu-myl-htgm-chmi-blcm-finl-bac-stm-ebio-twtr-snap-ttm", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-13-2017-chrs-ipar-iret-kmg-blcm-ryi-enz-gden-brew-lmnr", "https://www.nasdaq.com/articles/wednesday-sector-leaders-drugs-computer-peripherals-2017-03-08", "https://www.nasdaq.com/articles/heres-why-bellicum-pharmaceuticals-went-much-22-today-2017-03-08", "https://www.nasdaq.com/articles/health-care-sector-update-06292017-srneobsvblcm-2017-06-29", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-bellicum-pharmaceuticals-blcm-2017-02-13", "https://www.nasdaq.com/articles/better-buy-ionis-pharmaceuticals-inc-vs-bellicum-pharmaceuticals-2016-12-12", "https://www.nasdaq.com/articles/why-juno-therapeutics-inc-plummeted-today-2016-11-23", "https://www.nasdaq.com/articles/better-buy-agenus-inc-vs-bellicum-pharmaceuticals-inc-2016-10-18", "https://www.nasdaq.com/articles/2-cancer-therapy-stocks-are-ridiculously-cheap-right-now-2016-08-18", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-blcm-is-in-overbought-territory%3A-whats-next-2016-08-17", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-celldex-therapeutics-2016-08-03", "https://www.nasdaq.com/articles/better-buy-bellicum-pharmaceuticals-inc-vs-bluebird-bio-inc-2017-03-06", "https://www.nasdaq.com/articles/heres-why-bluebird-bios-shares-dropped-10-monday-2016-06-28", "https://www.nasdaq.com/articles/analysts-predict-34-gains-ahead-ibb-2016-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-04052016-blcmvrxagnpfe-2016-04-05", "https://www.nasdaq.com/articles/thursday-sector-leaders-drugs-biotechnology-stocks-2016-03-24", "https://www.nasdaq.com/articles/after-hours-earnings-report-march-14-2016-ttec-ingn-mnkd-akba-blcm-pfsw-rxdx-jmba-cui-tpvg", "https://www.nasdaq.com/articles/why-bluebird-bio-incs-stock-dropped-34-january-2016-02-08", "https://www.nasdaq.com/articles/2-beaten-down-biotech-stocks-buy-february-2016-02-06", "https://www.nasdaq.com/articles/cancer-stocks-2-buy-1-avoid-2016-07-23", "https://www.nasdaq.com/articles/heres-why-bluebird-bio-turned-disappointing-2015-2016-01-09", "https://www.nasdaq.com/articles/heres-why-juno-therapeutics-stock-dropped-20-december-2016-01-07", "https://www.nasdaq.com/articles/my-top-biotech-stock-2016-2016-01-05", "https://www.nasdaq.com/articles/2-biotech-stocks-watch-december-2015-11-20", "https://www.nasdaq.com/articles/health-care-sector-update-11102015-blcm-sphs-aegr-2015-11-10", "https://www.nasdaq.com/articles/why-bellicum-pharmaceuticals-soaring-today-2015-11-10", "https://www.nasdaq.com/articles/3-biotech-stocks-were-ready-sell-2015-10-18", "https://www.nasdaq.com/articles/why-bluebird-bio-incs-stock-bounced-back-2016-01-13", "https://www.nasdaq.com/articles/why-bellicum-pharmaceuticals-blcm-could-be-positioned-for-a-slump-2015-08-26", "https://www.nasdaq.com/articles/george-soros-fund-just-abandoned-promising-cancer-fighting-technology-should-you-2015-08", "https://www.nasdaq.com/articles/3-small-cap-biopharma-stocks-id-never-short-2015-08-12", "https://www.nasdaq.com/articles/what-cancer-immunotherapy-2015-06-21", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-slumps%3A-blcm-falls-9.6-in-session-tale-of-the-tape-2015-06-17", "https://www.nasdaq.com/articles/billionaire-george-soros-just-bought-highly-speculative-stock-should-you-2015-05-31", "https://www.nasdaq.com/articles/3-stocks-could-double-your-money-2015-05-30", "https://www.nasdaq.com/articles/health-care-sector-update-09112015-blcmarwrnwbo-2015-09-11", "https://www.nasdaq.com/articles/could-tiny-biotech-be-gilead-sciences-ma-radar-2015-05-16", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-inc.-blcm-in-focus%3A-stock-jumps-6.1-tale-of-the-tape-2015-03-20-0", "https://www.nasdaq.com/articles/10-billion-hedge-fund-just-bought-extremely-risky-stock-should-you-2015-03-07", "https://www.nasdaq.com/articles/top-rated-stock-picks-and-most-read-stories-nasdaqcom-feb-1-7-2015-2015-02-10", "https://www.nasdaq.com/articles/2-companies-redefining-cancer-treatment-2015-01-23", "https://www.nasdaq.com/articles/us-ipo-weekly-recap-record-2014-ipo-market-finishes-2-billion-cancer-biotech-2014-12-19", "https://www.nasdaq.com/articles/bellicum-pharmaceuticals-prices-upsized-ipo-19-above-range-2014-12-18", "https://www.nasdaq.com/articles/2-stocks-jaw-dropping-growth-potential-2015-05-17", "https://www.nasdaq.com/articles/week-ahead-2014-ipo-markets-final-round-6-ipos-planned-week-dec-15-2014-12-15", "https://www.nasdaq.com/articles/double-dose-immunotherapy-bellicum-pharmaceuticals-sets-terms-100-million-ipo-2014-12-09", "https://www.nasdaq.com/articles/juno-therapeutics-significantly-boosts-ipo-price-range-21-23-2014-12-16"], "Content": []}